Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
GXP-Storage Expands Global Reach with New U.K. Site
Material storage ecosystem includes sites in North Carolina's RTP and Biomanufacturing Crescent Region, and the U.K.'s Golden Triangle Region.
LGC Group Opens $100M Organic Chemistry Synthesis Centre of Excellence in Vaughan, Strengthening Canada’s Role in Global Life Sciences
LGC Group, a global leader in life sciences, today officially opened its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD$100 million investment. The 203,000 ft² (17,200 m²) facility is one of the largest of its kind in the world.
Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced an agreement with Rodon Global (“Rodon”), the established freight company focused on clinical trials and drug discovery headquartered in South Africa.
Bold Revival
A compelling optimism has surfaced across the global pharmaceutical and life science industry.
Rotzinger PharmaPack launches filling and capping platform
Rotzinger PharmaPack is launching a new filling and capping platform for over-the-counter (OTC) products such as non-aseptic pharmaceuticals as well as solid and liquid products from the cosmetics, personal care, and nutraceutical industries.
Trump demands pharmaceutical companies release Covid drug success rates
Trump's demand to make the data public comes amid escalating divisions between the Centers for Disease Control and Prevention and HHS Secretary Robert F. Kennedy Jr.
eXmoor Pharma & Anthony Nolan Partner to Advance Cell Therapy Development
eXmoor Pharma, a UK-based contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, has entered a strategic partnership with Anthony Nolan Cell Therapy & Laboratory Services (CT&LS), a leader in cellular starting materials, to provide an integrated solution for cell therapy developers.
Accro Bioscience Grants Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor in Greater China
Accro Bioscience, a biotechnology company, has entered into an agreement granting Fosun Pharma exclusive rights to develop, manufacture, and commercialize its TYK2/JAK1 inhibitor, AC-201, in Greater China, encompassing Chinese Mainland, Hong Kong SAR, and Macau SAR. Accro will retain global rights for AC-201 outside these regions.
Irish pharma risks hostage situation as EU weighs DSA and Ukraine criticism
The US is losing patience with the EU on digital policy and its Ukraine long game; Ireland’s pharma negotiations could be hostage to a wider standoff
India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger
India plans to increase pharmaceutical exports to Russia, the Netherlands and Brazil, according to two industry sources aware of the matter, aiming to expand its presence beyond the United States, its largest market, amid tariff-related concerns.


Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
